TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24491137

Group type: EXPERIMENTAL
Intervention: Taking Healthy Steps (Internet-mediated walking program)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 239
Study: 17936382

Group type: EXPERIMENTAL
Intervention: Proxy‐obtained information from primary caregiver
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Impairment in activities of daily living (ADL)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric symptoms
Number of subjects: 330
Study: 15126518

Group type: EXPERIMENTAL
Intervention: Buccal system (Striant), applied twice daily for 7 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Transdermal patch (Andropatch or Androderm), applied daily for 7 days
Number of subjects: 66
Study: 11044760

Group type: EXPERIMENTAL
Intervention: Simvastatin 2.5 mg
Number of subjects: 14130

Group type: EXPERIMENTAL
Intervention: Simvastatin 5 mg
Number of subjects: 14130

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.2 mg
Number of subjects: 14130

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg
Number of subjects: 14130

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 14130

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 14130

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 14130
Study: 9296510

Group type: EXPERIMENTAL
Intervention: Hand-sewn anastomosis
Number of subjects: 122

Group type: COMPARATOR
Intervention: Stapled anastomosis
Number of subjects: 122
Study: 7975414

Group type: EXPERIMENTAL
Intervention: Diet therapy with additional provision of vegetables, fruit, and greens
Number of subjects: 0
Study: 3547009

Group type: EXPERIMENTAL
Intervention: 75 g of glucose in 350 ml of water (GLU)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 75 g of fructose in 350 ml of water (FRU)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 350 ml of an artificially sweetened and flavored placebo (CON)
Number of subjects: 6
Study: 30580490

Group type: EXPERIMENTAL
Intervention: Activated carbon nanoparticles (ACNs) injection (1 ml) in the subserosa around the tumour before colectomy and D3 lymphadenectomy.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no ACN injection).
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Activated carbon nanoparticles (ACNs) injection.
Number of subjects: 80
Study: 28687711

Group type: EXPERIMENTAL
Intervention: Norwood to Stage 2 Palliation (S2P) interval of 3 to 6 months
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Stage 2 Palliation (S2P)
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Risk-adjusted, 3-year TFS
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Survivors to S2P
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: 3-year follow-up after S2P
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Optimal timing of S2P
Number of subjects: 547
Study: 26427723

Group type: EXPERIMENTAL
Intervention: Trivalent-inactivated vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Live-attenuated vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Titer of 1:40
Number of subjects: 0

Group type: COMPARATOR
Intervention: Titer of 1:80
Number of subjects: 0
Study: 25249036

Group type: EXPERIMENTAL
Intervention: Children with at most one negative lifestyle factor (n = 48)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Children with two negative lifestyle factors (n = 64)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Children with three negative lifestyle factors (n = 56)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Children with four negative lifestyle factors (n = 41)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Children with five or more negative lifestyle factors (n = 14)
Number of subjects: 502
Study: 23121733

Group type: EXPERIMENTAL
Intervention: CKD‐EPI eGFR <60 mL/min/1.73m2
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Albuminuria with eGFR ≥60 mL/min/1.73 m2
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: National Kidney Foundation (NKF) defined CKD
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: MDRD related estimates for eGFR <60 mL/min/1.73 m2
Number of subjects: 1098
Study: 19708471

Group type: COMPARATOR
Intervention: Qigong Sensory Training (QST) - a qigong massage intervention, involving 20 sessions over 5 months, with daily parental massage.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 46
Study: 18165528

Group type: EXPERIMENTAL
Intervention: Levamisole administered bimonthly to 107 subjects
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group of 105 subjects
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Levamisole administered to children 5-14 years
Number of subjects: 212
Study: 15509817

Group type: EXPERIMENTAL
Intervention: Traditional schedule (extended work shifts of 24 hours or more)
Number of subjects: 634
Study: 11903763

Group type: EXPERIMENTAL
Intervention: One-hour didactic session, the use of well‐built clinical question cards, and practical sessions in clinical question building.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 48
Study: 9389844

Group type: EXPERIMENTAL
Intervention: Single, end-holed extradural catheters
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Multi-orifice extradural catheters
Number of subjects: 364
Study: 7702414

Group type: EXPERIMENTAL
Intervention: Standard duration balloon inflation (< or = 3 min)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Prolonged duration balloon inflation (>= 12 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 27
Study: 3584580

Group type: EXPERIMENTAL
Intervention: PA Patch
Number of subjects: 9

Group type: COMPARATOR
Intervention: Finn Chamber
Number of subjects: 9
Study: 31478095

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) + Exercise
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo HILT + Exercise
Number of subjects: 42
Study: 28901958

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice (240 mL 2 times/d for 2 weeks)
Number of subjects: 8
Study: 26669504

Group type: EXPERIMENTAL
Intervention: Xeno V(+) etch
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Clearfil SE non-etch
Number of subjects: 112

Group type: COMPARATOR
Intervention: Clearfil SE Bond (etch)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Xeno V(+) (non-etch)
Number of subjects: 112
Study: 24763930

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg once daily; 15 mg once daily for creatinine clearance of 30‐49 mL/min
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 932

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 932
Study: 24429202

Group type: EXPERIMENTAL
Intervention: Calcium and calcifediol
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 20544937

Group type: EXPERIMENTAL
Intervention: Intramuscular BoNT‐A injections at 6‐month intervals in the tibialis posterior and peroneus longus.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control leg received no injections.
Number of subjects: 10
Study: 18773722

Group type: EXPERIMENTAL
Intervention: Kinetic pattern with circular illusory apertures revealing drifting gratings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Static jagged diamond with varying shapes and edge discontinuities
Number of subjects: 0
Study: 17061020

Group type: EXPERIMENTAL
Intervention: Percussive ventilation (IMP2 Breas, Sweden) 10 min twice/day in addition to chest physiotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Chest physiotherapy (control)
Number of subjects: 46
Study: 14581257

Group type: EXPERIMENTAL
Intervention: Dedicated medication nurses
Number of subjects: 24

Group type: COMPARATOR
Intervention: General nurses
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dedicated medication nurses at hospital B
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dedicated medication nurses at hospital A
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dedicated medication nurses in surgical units at hospital A
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dedicated medication nurses in medical units
Number of subjects: 24
Study: 10766405

Group type: EXPERIMENTAL
Intervention: Hypertriglyceridaemia (HTG)
Number of subjects: 163
Study: 8829166

Group type: EXPERIMENTAL
Intervention: Death education (three two-hour didactic/experiential classes)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Death education
Number of subjects: 28
Study: 1573544

Group type: EXPERIMENTAL
Intervention: Citric acid treatment for 30, 60, 120, or 240 seconds
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tetracycline HCl treatment for 30, 60, 120, or 240 seconds
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 20
Study: 3933330

Group type: EXPERIMENTAL
Intervention: Penicillin V given twice daily (250 mg for ten days)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Penicillin V given three times daily (250 mg for ten days)
Number of subjects: 99
Study: 30805104

Group type: EXPERIMENTAL
Intervention: Flipped classroom
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard classroom
Number of subjects: 63
Study: 29031769

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 100 U
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 19
Study: 26957322

Group type: EXPERIMENTAL
Intervention: Complementary school garden, nutrition and WASH intervention
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Control (no interventions)
Number of subjects: 1144
Study: 24619932

Group type: EXPERIMENTAL
Intervention: LY2456302 (2-60 mg single doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY2456302 (2, 10, and 35 mg multiple doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY2456302 co-administered with ethanol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY2456302
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol (in presence of LY2456302)
Number of subjects: 0
Study: 22454189

Group type: EXPERIMENTAL
Intervention: 12‐month CHW intervention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Enhanced usual care (educational materials mailed at 4‐month intervals, preceded by phone calls)
Number of subjects: 360
Study: 20076848

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily for five days
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg daily for five days
Number of subjects: 56
Study: 17441658

Group type: EXPERIMENTAL
Intervention: Navigated total knee arthroplasty using a computed navigation system
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty technique
Number of subjects: 42
Study: 16254220

Group type: EXPERIMENTAL
Intervention: Higher baseline systolic BP or diastolic BP
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Lower within-patient 0- to 72-hour average systolic BP or diastolic BP
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Reduced variability of 0- to 72-hour diastolic BP profile
Number of subjects: 615
Study: 12216025

Group type: EXPERIMENTAL
Intervention: Continuous-flow cooling device applied over the surgical dressing immediately postoperatively
Number of subjects: 30

Group type: COMPARATOR
Intervention: No cooling device (control TKA)
Number of subjects: 30
Study: 9502680

Group type: EXPERIMENTAL
Intervention: Pulse-spray thrombolysis with high-dose urokinase
Number of subjects: 24

Group type: COMPARATOR
Intervention: Continuous-infusion thrombolysis with high-dose urokinase
Number of subjects: 24
Study: 7633701

Group type: EXPERIMENTAL
Intervention: Epinephrine (2 mg bolus followed by 2 mg every 4 min)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Methoxamine (40 mg bolus followed after 4 min by 40 mg)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Methoxamine
Number of subjects: 145
Study: 2520343

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide, daily dose 4 x 0.1 mg for 6 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 20284

Group type: EXPERIMENTAL
Intervention: Clorazepate 15 mg at bedtime
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diazepam thrice daily
Number of subjects: 40
Study: 31794928

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 334

Group type: COMPARATOR
Intervention: Cetuximab
Number of subjects: 334
Study: 29772928

Group type: EXPERIMENTAL
Intervention: Clinical carepath for obese pregnant women
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 189
Study: 27762648

Group type: EXPERIMENTAL
Intervention: G1 tumors (Luminal A-like)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: G3 tumors (Luminal A-like)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: G2 tumors
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: G1 tumors (Luminal B-like)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: G3 tumors (Luminal B-like)
Number of subjects: 671
Study: 26112224

Group type: EXPERIMENTAL
Intervention: Nurse-led psychoeducational intervention for 36 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Augmented usual care
Number of subjects: 120
Study: 23583056

Group type: EXPERIMENTAL
Intervention: Topiramate monotherapy for ≥6 months
Number of subjects: 117
Study: 21713025

Group type: EXPERIMENTAL
Intervention: Ofloxacin treatment with MIC ≤0.125 µg/mL
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Ofloxacin treatment with MIC between 0.25 and 0.50 µg/mL
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Ofloxacin treatment with MIC 1.00 µg/mL
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Ofloxacin treatment with MIC ≥0.25 µg/mL
Number of subjects: 540
Study: 19903189

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Amiodarone + Propranolol
Number of subjects: 240
Study: 16689844

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) catheter ablation
Number of subjects: 142
Study: 15542798

Group type: EXPERIMENTAL
Intervention: Vaccination with four gp100‐ and tyrosinase‐derived peptides plus low-dose IL-2 administered daily beginning day 28 (group 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vaccination with four gp100‐ and tyrosinase‐derived peptides plus low-dose IL-2 administered daily beginning day 7 (group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Control group (group 2)
Number of subjects: 40
Study: 10674497

Group type: EXPERIMENTAL
Intervention: 902 MHz electromagnetic field emitted by cellular telephones
Number of subjects: 48

Group type: COMPARATOR
Intervention: No exposure to the electromagnetic field
Number of subjects: 48
Study: 9316778

Group type: EXPERIMENTAL
Intervention: PAPNET screening
Number of subjects: 5037

Group type: COMPARATOR
Intervention: Manual screening
Number of subjects: 5037

Group type: EXPERIMENTAL
Intervention: PAPNET screening (post-review)
Number of subjects: 5037

Group type: COMPARATOR
Intervention: Manual screening (post-review)
Number of subjects: 5037

Group type: EXPERIMENTAL
Intervention: PAPNET screening with specific triage protocol
Number of subjects: 5037
Study: 8222172

Group type: EXPERIMENTAL
Intervention: Left Ventricular Assist Device (LVAD)
Number of subjects: 8
Study: 3949375

Group type: EXPERIMENTAL
Intervention: Diltiazem monotherapy for 8 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diltiazem therapy in subjects with pretreatment glomerular filtration rates of 80 ml/min/1.73 m2 or less
Number of subjects: 18
Study: 3124898

Group type: EXPERIMENTAL
Intervention: Vibration perception threshold measured with a biothesiometer in diabetic patients
Number of subjects: 174

Group type: COMPARATOR
Intervention: Vibration perception threshold measured with a biothesiometer in non-diabetic subjects
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 174
Study: 31209428

Group type: EXPERIMENTAL
Intervention: Goserelin with chemotherapy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Chemotherapy without goserelin
Number of subjects: 101
Study: 28499368

Group type: EXPERIMENTAL
Intervention: Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: WEMWBS and SWEMWBS
Number of subjects: 1168
Study: 26281052

Group type: EXPERIMENTAL
Intervention: FESS associated with inferior turbinate lateral fracture and radiofrequency ablation treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: FESS associated with inferior turbinate lateral fracture treatment
Number of subjects: 54
Study: 23374902

Group type: EXPERIMENTAL
Intervention: Mindfulness-based group intervention
Number of subjects: 71
Study: 21455643

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 30
Study: 18005926

Group type: EXPERIMENTAL
Intervention: Incongruent distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Congruent distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response durations
Number of subjects: 0
Study: 17225672

Group type: EXPERIMENTAL
Intervention: Bimoraic foot boundary
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticipatory V-to-V effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foot constraint
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Idiosyncratic variation across speakers
Number of subjects: 0
Study: 12859126

Group type: EXPERIMENTAL
Intervention: High-quality center-based care (full-day care, 50 weeks per year) for > 400 days
Number of subjects: 1082

Group type: EXPERIMENTAL
Intervention: High-quality center-based care for heavier LBW infants (2,001-2,500 g) for > 400 days
Number of subjects: 1082

Group type: EXPERIMENTAL
Intervention: High-quality center-based care for lighter LBW infants (<= 2,000 g) for > 400 days
Number of subjects: 1082

Group type: EXPERIMENTAL
Intervention: High-quality center-based care for > 350 days
Number of subjects: 1082
Study: 11063475

Group type: EXPERIMENTAL
Intervention: Behavioral intervention promoting a diet providing 28% of energy from total fat, <8% from saturated fat, </=9% from polyunsaturated fat, and <0.018 mg cholesterol*kJ(‐)(1)*d(‐)(1) (not to exceed 150 mg/d)
Number of subjects: 663

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 663

Group type: COMPARATOR
Intervention: Comparison of intervention vs usual care
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 663
Study: 9111818

Group type: EXPERIMENTAL
Intervention: JM‐13 staining in psoriasis
Number of subjects: 0

Group type: COMPARATOR
Intervention: JM‐13 staining in uninvolved and normal skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JM‐403 staining in all specimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: JM‐403 staining in normal skin
Number of subjects: 0

Group type: COMPARATOR
Intervention: JM‐403 staining in uninvolved skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JM‐403 staining in psoriatic skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JM‐72 staining in all biopsies
Number of subjects: 0
Study: 1606981

Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mitomycin C
Number of subjects: 60
Study: 4036631

Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg (NZ)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg (TZ)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg (DZ)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alprazolam 0.25 mg (AZ)
Number of subjects: 32
Study: 30141292

Group type: EXPERIMENTAL
Intervention: Acupuncture at proximal and distal acupoints combined with NMES (20 min), oral function training (30 min), scalp acupuncture (1 h), body acupuncture (30 min), pricking blood at Jinjin and Yuye for patients of grade Ⅴ in TDS, treatment for 3 courses, 30 days, 5 times a week, once a day.
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Acupuncture at proximal and distal acupoints combined with NMES (20 min), oral function training (30 min).
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group received NMES (20 min) and oral function training (30 min).
Number of subjects: 124
Study: 27010558

Group type: EXPERIMENTAL
Intervention: Midurethral sling (MUS) surgery
Number of subjects: 236
Study: 24326812

Group type: EXPERIMENTAL
Intervention: Ankaferd Blood Stopper (ABS) - 1.0 mL administered to one half of the sockets
Number of subjects: 50

Group type: COMPARATOR
Intervention: Physiological serum - 1.0 mL irrigated in the control half of the sockets
Number of subjects: 50
Study: 23030566

Group type: EXPERIMENTAL
Intervention: Discharge instructions combined with information consistent with health literacy level (Experiment 1)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Discharge instructions tailored to both health literacy and learning style preferences (Experiment 2)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Routine discharge instructions (Control group in Experiment 1)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Information customized for health literacy level only (Control group in Experiment 2)
Number of subjects: 172
Study: 19959271

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 7

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 7
Study: 17901958

Group type: EXPERIMENTAL
Intervention: Computer-aided detection (CAD) tool
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Experienced radiologists (R1, R2)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Inexperienced radiologists (R3, R4)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: CAD
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Experienced readers (R1, R2)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Inexperienced readers (R3, R4)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Experienced vs inexperienced readers
Number of subjects: 56